AcquisitionOther
Myovant Sciences Ltd. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Myovant Sciences Ltd. -> target · $1.7 billion
“This transaction represents an industry-leading opportunity to combine unique expertise, platforms, and resources to successfully commercialize products in Myovant’s program and to accelerate development of a robust pipeline addressing patient needs in women’
Open source record (SEC) ↗